스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 0,375 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.375 mg corresp. pramipexolum 0.262 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 0,75 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.750 mg corresp. pramipexolum 0.524 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 1,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 1.500 mg corresp. pramipexolum 1.049 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 3,0 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 3.00 mg corresp. pramipexolum 2.097 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
sifrol er 4,5 mg retardtabletten
boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 4.500 mg corresp. pramipexolum 3.146 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
ranexa 375 mg retardtabletten
a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 375 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.15 mg, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, cera carnauba, e 171, e 132, pro compresso obducto. - angina pectoris - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
ranexa 500 mg retardtabletten
a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - angina pectoris - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
ranexa 750 mg retardtabletten
a. menarini gmbh - ranolazinum - retardtabletten - ranolazinum 750 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 2.29 mg, Überzug: triacetinum, hypromellosum, lactosum monohydricum 12 mg, cera carnauba, e 171, e 102 40 µg, e 133, pro compresso obducto. - angina pectoris - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
esomep 20 mg mup-tabletten
grünenthal pharma ag - esomeprazolum - mup-tabletten - esomeprazolum 20 mg a esomeprazolum magnesicum trihydricum, glyceroli monostearas 40-55, hydroxypropylcellulosum, hypromellosum, magnesio stearas, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, cellulosum microcristallinum, paraffinum solido syntheticum, macrogolum 6000, polysorbatum 80, crospovidonum, natrii stearylis fumaras, zucchero sfere, talco, triethylis citras, e 171, e 172 (giallo) e 172 (rosso), per compresso corrisp. sodio 0.034 mg. - protonenpumpenblocker - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
esomep 40 mg mup-tabletten
grünenthal pharma ag - esomeprazolum - mup-tabletten - esomeprazolum 40 mg a esomeprazolum magnesicum trihydricum, glyceroli monostearas 40-55, hydroxypropylcellulosum, hypromellosum, magnesio stearas, acidi methacrylici e ethylis acrylatis polymerisatum 1:1, cellulosum microcristallinum, paraffinum solido syntheticum, macrogolum 6000, polysorbatum 80, crospovidonum, natrii stearylis fumaras, zucchero sfere, talco, triethylis citras, e 171, e 172 (rosso), per compresso haze corrisp. sodio 0.048 mg. - protonenpumpenblocker - synthetika